Frontlight ResearchEarly access
Trial site
Sana Kliniken Berlin-Brandenburg GmbH
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer5 trials
- Colorectal cancer1 trial
- Eosinophilic oesophagitis1 trial
- Gastric and oesophageal cancer1 trial
- Gastroparesis1 trial
- High blood pressure1 trial
- Liver and biliary tract cancer1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 21 trial
- Status
- Recruiting6 trials
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- AstraZeneca2 trials
- Dr. Falk Pharma GmbH2 trials
- Revolution Medicines Inc.2 trials
- Revolution Medicines, Inc.2 trials
- Boehringer Ingelheim1 trial
- and 2 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer5 recruiting
- Gastric and oesophageal cancer1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026